Infection Management

Daniel C DeSimone; Muhammad Rizwan Sohail

doi:10.1016/j.ccep.2018.04.002

Infection Management

Card Electrophysiol Clin. 2018 Dec;10(4):601-607. doi: 10.1016/j.ccep.2018.04.002.

Authors

Daniel C DeSimone¹, Muhammad Rizwan Sohail²

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA. Electronic address: desimone.daniel@mayo.edu.
² Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA.

PMID: 30396574
DOI: 10.1016/j.ccep.2018.04.002

Abstract

Cardiovascular implantable electronic devices (CIEDs) and the indications for their use have significantly risen over the past decades to include patients who are older with more medical comorbidities. Predictably, the rates of CIED infection have increased substantially. CIED infection is associated with high morbidity, mortality, and financial costs. This article discusses the appropriate management of CIED infections, which is imperative to limit the problems associated with infection.

Keywords: AHA guidelines; Device infection; Lead extraction; Sonication; TEE.

Publication types

Review

MeSH terms

Defibrillators, Implantable / adverse effects*
Device Removal
Echocardiography, Transesophageal
Humans
Pacemaker, Artificial / adverse effects*
Prosthesis-Related Infections* / diagnosis
Prosthesis-Related Infections* / prevention & control
Prosthesis-Related Infections* / therapy
Sonication